ReShape Lifesciences, Inc. - Common Stock (RSLS)
Competitors to ReShape Lifesciences, Inc. - Common Stock (RSLS)
Apollo Endosurgery, Inc.
Apollo Endosurgery is a direct competitor in the field of minimally invasive medical devices for weight loss and gastrointestinal procedures. They offer the OverStitch endoscopic system and the ORBERA balloon system, which provide alternative weight loss options to the products offered by ReShape Lifesciences. Apollo's focus on innovative endoscopic technologies gives it a competitive edge in terms of procedure efficiency and patient recovery time.
Johnson & Johnson JNJ -4.12%
Johnson & Johnson, through its Ethicon division, offers surgical solutions that compete with ReShape Lifesciences in the area of obesity treatment and metabolic surgery. J&J benefits from its vast resources, experience in surgical procedures, and established reputation in the healthcare sector, granting them a significant advantage in market penetration and consumer loyalty.
Medtronic plc MDT -5.70%
As a major player in the medical device market, Medtronic competes indirectly with ReShape Lifesciences by providing a broader spectrum of surgical solutions, including weight-loss products and tools for metabolic surgery. With a strong financial foundation and extensive global reach, Medtronic's capabilities in research and development provide them with a significant advantage in innovation and customer trust, making them a formidable competitor.
Sientra, Inc.
Sientra operates in the field of breast aesthetics and reconstructive surgery, which includes weight management solutions alongside their breast implant offerings. While they are not a direct competitor, their focus on surgical aesthetics and innovations in procedures that may overlap with ReShape's offerings allows them to capture part of the patient demographic seeking weight loss solutions, particularly post-surgery aesthetics.